NCT03691142View on ClinicalTrials.gov

Evaluation of Obstetrical and Neonatal Complications in Hereditary Haemorrhagic Telangiectasia (HHT)

CompletedOBSERVATIONAL

Enrollment

207

Participants

Timeline

Start Date

October 2, 2018

Primary Completion Date

October 2, 2019

Study Completion Date

October 2, 2019

Conditions

Osler Rendu DiseaseHereditary Hemorrhagic Telangiectasia

Interventions

OTHER

Questionnaire

Interview of women with Hereditary Haemorrhagic Telangiectasia (HHT) during a consultation in the Reference Center for HHT or through a phone questionnaire about obstetric history, complications during pregnancy, delivery and neonatal outcomes.

Trial Locations (1)

69677

Centre de Référence pour la maladie de Rendu-Osler Service Génétique Clinique Bâtiment A1 - Hôpital Femme-Mère-Enfant - Hospices Civils de Lyon, Bron

All Listed Sponsors

lead

Hospices Civils de Lyon

OTHER

NCT03691142 - Evaluation of Obstetrical and Neonatal Complications in Hereditary Haemorrhagic Telangiectasia (HHT) | Biotech Hunter | Biotech Hunter